Evaluation of a Radial Arterial Line's Effect on StO2 Monitoring

This study has been completed.

Sponsored by:	The University of Texas Health Science Center at San Antonio
Information provided by:	The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:	NCT00298090

Purpose

Measuring St02 in the thenar eminence is emerging as a measurement of resuscitation. However, no study to our knowledge has evaluated the effects of an arterial line in the radial artery supplying this muscle bed on St02. This study will attempt to address the interaction between an arterial line and St02 monitoring in the thenar eminence. As most patients who require aggressive resuscitation will have an arterial line, it is important to understand what if any impact this will have on St02 in the same extremity.

Condition	Intervention
Arterial Lines	Device: StO2 monitoring

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Active Control, Single Group Assignment
Official Title:	An Evaluation of a Radial Arterial Line's Effect on StO2 Monitoring Using the InSpectra® Tissue Spectrometer

Further study details as provided by The University of Texas Health Science Center at San Antonio:

Primary Outcome Measures:

This study is designed to determine if the presence of a radial arterial line has an effect on St02 (tissue oxygen saturation) in the same extremity. [ Time Frame: 15 minutes ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

see primary outcome [ Time Frame: see primary outcome ] [ Designated as safety issue: No ]

Estimated Enrollment:	30
Study Start Date:	January 2006
Study Completion Date:	March 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Standard of care placement of arterial line
18 years of age or older

Exclusion Criteria:

Pregnant females
Nursing mothers
Prisoners

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00298090

Locations

United States, Texas
University Hospital
San Antonio, Texas, United States, 78229

Sponsors and Collaborators

The University of Texas Health Science Center at San Antonio

Investigators

Principal Investigator:

Lopez P Peter, M.D.

University of Texas Health Science Center San Antonio

More Information

device information This link exits the ClinicalTrials.gov site

Study ID Numbers:	045-1502-319, 045-1502-319
Study First Received:	February 27, 2006
Last Updated:	May 26, 2008
ClinicalTrials.gov Identifier:	NCT00298090
Health Authority:	United States: Food and Drug Administration

ClinicalTrials.gov processed this record on January 16, 2009